Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden

References

• Causes of death 2005. National Board of Health and Welfare, Stockholm, Sweden; 2007. http://www.socialstyrelsen.se/NR/rdonlyres/8747C5D3-700D-4517-8E1F-510FAB8B02C4/9419/20074218.pdf ( accessed 14 April 2008).
   Google Scholar
• Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andren O, et al. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 2007; 41: 456–77
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977–84
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Inst 2008; 100: 1144–54
   PubMed Web of Science ®Google Scholar
• Regional Oncological Center. The National Prostate Cancer Register (NPCR) in Sweden 2002–2006, Uppsala; 2008. http://www.roc.se/prostata/rapport/rapport_02_06.pdf (accessed 14 April 2008).
   Google Scholar
• Lepor H, Nieder AM, Ferrandino MN. Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol 2001; 166: 1729–33
   PubMed Web of Science ®Google Scholar
• Arai Y, Egawa S, Tobisu K, Sagiyama K, Sumiyoshi Y, Hashine K, et al. Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan. BJU Int 2000; 85: 287–94
   PubMed Web of Science ®Google Scholar
• Alibhai SM, Leach M, Tomlinson G, Krahn MD, Fleshner N, Holowaty E, et al. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005; 97: 1525–32
   PubMedGoogle Scholar
• Lu-Yao GL, Albertsen P, Warren J, Yao SL. Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy – a population-based study. Urology 1999; 54: 301–7
   PubMed Web of Science ®Google Scholar
• Karakiewicz, PI, Bazinet, M, Aprikian, AG, Tanguay, S, Elhilali, MM. Thirty-day mortality rates and cumulative survival after radical retropubic prostatectomy. Urology 1998;521041–6.
   Web of Science ®Google Scholar
• Andriole GL, Smith DS, Rao G, Goodnough L, Catalona WJ. Early complications of contemporary anatomical radical retropubic prostatectomy. J Urol 1994; 152: 1858–60
   PubMed Web of Science ®Google Scholar
• Regionalt Onkologiskt Centrum. www.roc.se (accessed 3 January 2008).
   Google Scholar
• NOMESKO and National Board of Health and Welfare S. Classification of surgical procedures. Version 1.9. Lindesberg: Bergslagens Grafiska; 2004.
   Google Scholar
• Begg CB, Riedel ER, Bach PB, Kattan MW, Schrag D, Warren JL, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002; 346: 1138–44
   PubMed Web of Science ®Google Scholar
• Leandri P, Rossignol G, Gautier JR, Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992; 147: 883–7
   PubMed Web of Science ®Google Scholar
• Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA 1993; 269: 2633–6
   PubMed Web of Science ®Google Scholar
• Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850–7
   PubMed Web of Science ®Google Scholar
• Mark DH. Mortality of patients after radical prostatectomy: analysis of recent Medicare claims. J Urol 1994; 152: 896–8
   PubMed Web of Science ®Google Scholar
• Optenberg SA, Wojcik BE, Thompson IM. Morbidity and mortality following radical prostatectomy: a national analysis of Civilian Health and Medical Program of the Uniformed Services beneficiaries. J Urol 1995; 153: 1870–2
   PubMed Web of Science ®Google Scholar
• Dillioglugil O, Leibman BD, Leibman NS, Kattan MW, Rosas AL, Scardino PT. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 1997; 157: 1760–7
   PubMed Web of Science ®Google Scholar
• Yao S-L, Lu-Yao G. Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst 1999; 22: 1950–6
   Google Scholar
• Wilt TJ, Cowper DC, Gammack JK, Going DR, Nugent S, Borowsky J. An evaluation of radical prostatectomy at Veterans Affairs medical centers: time trends and geographic variation in utilization and outcomes. Med Care 1999; 37: 1046–56
   PubMed Web of Science ®Google Scholar
• Ellison LM, Heaney JA, Birkmeyer JD. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 2000; 163: 867–9
   PubMed Web of Science ®Google Scholar
• Alibhai SM, Leach M, Tomlinson G. Examining the location and cause of death within 30 days of radical prostatectomy. BJU Int 2005; 95: 541–4
   PubMedGoogle Scholar
• Bianco FJ, Jr, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005; 173: 2099–103
   PubMed Web of Science ®Google Scholar
• Konety BR, Allareddy V, Modak S, Smith B. Mortality following major surgery for urologic cancers in specialized urology hospitals: are they any better?. J Clin Oncol 2006; 24: 2006–12
   PubMed Web of Science ®Google Scholar
• Judge A, Evans S, Gunnell DJ, Albertsen PC, Verne J, Martin RM. Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episode statistics for England. BJU Int 2007; 100: 1040–9
   PubMed Web of Science ®Google Scholar
• Bubolz T, Wasson JH, Lu-Yao G, Barry MJ. Treatments for prostate cancer in older men: 1984–1997. Urology 2001; 58: 977–82
   PubMed Web of Science ®Google Scholar
• Stattin, P. Surveillance for localized prostate cancer. A population-based study in the National Prostate Cancer Register (NPCR) in Sweden. 2008 Genitourinary Cancers Symposium American Society of Clinical Oncology (ASCO); 2008.
   Google Scholar
• Alibhai SM, Leach M, Tomlinson G, Krahn MD, Fleshner N, Naglie G. Rethinking 30-day mortality risk after radical prostatectomy. Urology 2006; 68: 1057–60
   PubMed Web of Science ®Google Scholar
• Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G. Is there age bias in the treatment of localized prostate carcinoma?. Cancer 2004; 100: 72–81
   PubMed Web of Science ®Google Scholar
• Otto SJ, Schroder FH, de Koning HJ. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial. J Clin Oncol 2006; 24: 4184–9
   PubMed Web of Science ®Google Scholar
• Klevecka V, Burmester L, Musch M, Roggenbuck U, Kroepfl D. Intraoperative and early postoperative complications of radical retropubic prostatectomy. Urol Int 2007; 79: 217–25
   PubMed Web of Science ®Google Scholar
• Noldus J, Hammerer P, Graefen M, Huland H. Surgical therapy for localized prostatic carcinoma. J Cancer Res Clin Oncol 1997; 123: 180–4
   PubMed Web of Science ®Google Scholar
• Pedersen KV, Herder A. Radical retropubic prostatectomy for localised prostatic carcinoma: a clinical and pathological study of 201 cases. Scand J Urol Nephrol 1993; 27: 219–24
   PubMed Web of Science ®Google Scholar